Cerity Partners LLC Century Therapeutics, Inc. Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 14,260 shares of IPSC stock, worth $7,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,260Holding current value
$7,985% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
73Shares Held
33.4MCall Options Held
9.7KPut Options Held
1.5K-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.03 Million1.48% of portfolio
-
Casdin Capital, LLC New York, NY5.19MShares$2.91 Million0.45% of portfolio
-
Vr Adviser, LLC New York, NY3.96MShares$2.22 Million0.66% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.33 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $33M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...